Company
United StatesJuno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb, Seattle, WA – FDA Inspections
Inspection records and compliance data for Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb in Seattle, Washington. 2 FDA inspections on record, last inspected March 18, 2022.
Company Profile
This profile covers Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb based in Seattle, Washington, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected May 15, 2019. Last inspected March 18, 2022.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 18, 2022 | NAI | Biologics · Vaccines and Allergenic Products | 1165379 |
| May 15, 2019 | NAI | Biologics · Bioresearch Monitoring | 1091219 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Diagnostic Services of Kansas State, Inc.
2seventy Bio, Inc.
University of Massachusetts Incorporated
Valneva Austria GmbH
Replimune Limited
Laboratorio de Control ARJ, S.A. de C.V.
Emergent Biosolutions LLC
Haematologic Technologies, LLC dba Prolytix
Sarepta Therapeutics Inc
Charles River Laboratories, Inc. DBA Charles River, Endosafe
Company Information
Name
Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb
FEI Number
3010932912
Address
400 Dexter Ave N Fl 12, Seattle, Washington 98109, United States
Country
United States
ID: fff03cc2-ba14-4ac1-b81c-88b6bebad784